A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Clinical trial NCT02208063 · TERMINATED
Trial details
- NCT number
- NCT02208063
- Sponsor
- Cumberland Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-04-12
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.